New study aims to develop treatment for Crohn's
New study aims to develop treatment for Crohn's

A global team of researchers are working to develop more effective treatment for people living with Crohn's disease.

Six nations are participating in new study aimed at fighting the gastrointestinal disease. New Zealand with 20000 people with the disease, is participating in the study.MAP US will provide three antibiotics in the form of a pill to three groups of participants, who will be divided, form a total of 270 people. The researchers said that the participants will go into remission at week 26 of the study but that may depends on the research and study. The study is expected to go on for a period of 62 weeks. The study gives hopes to those living with the disease.

Professor Thomas Borody has helped develop the test behind the study. In his approach, the treatment treats the cause as infectious, which is Mycobacterium avium subsp. paratuberculosis (MAP).Borody said the drug would be most effective for those had recently been diagnosed with Crohn's.
Crohn's and Colitis New Zealand chairman Brian Poole said, "If you can imagine a bowel that's being emptied 20 or 30 times a day, it breaks your confidence. People don't like talking about their bowels."